Insiders · ASTH

David Schmidt

Director at Astrana Health, Inc. (ASTH)

David Schmidt has filed 11 insider reports with the SEC since August 2021, as director at Astrana Health, Inc. (ASTH). David Schmidt made no open-market purchases or sales in the last 12 months. The latest filing, on August 18, 2026, reports sale back to the company and exercise or conversion of a derivative at Astrana Health, Inc. (ASTH).

Filings
11
Companies
1
Bought on market
None
Sold on market
$2.95M

Companies where David Schmidt is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Astrana Health, Inc. logo
ASTH
Astrana Health, Inc.
Director36,019$2.95M$29.65Aug 18, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David Schmidt with

Other insiders at the same companies

Questions about David Schmidt

What is David Schmidt's role at Astrana Health, Inc.?
David Schmidt reports to the SEC as director at Astrana Health, Inc. (ASTH), according to the latest filing on August 18, 2026.
How many shares does David Schmidt own?
After the latest filing that states it, David Schmidt directly owned 36,019 shares of Astrana Health, Inc. (ASTH). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David Schmidt bought or sold stock recently?
The most recent open-market sale was on August 17, 2021: sold 40,000 shares of Apollo Medical Holdings, Inc. (ASTH) for $2.95M at an average of $73.67.
How do I get alerts when David Schmidt files?
Follow David Schmidt on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Schmidt (SEC CIK 0001594029). Totals count each trade once, skipping amendments whose original is on file, from Aug 19, 2021 on. View on SEC EDGAR